Rational design, optimization, and biological evaluation of novel α-Phosphonopropionic acids as covalent inhibitors of Rab geranylgeranyl transferase

References

• De Cesco S, Kurian J, Dufresne C, et al. Covalent inhibitors design and discovery. Eur J Med Chem 2017;138:96–114.
   PubMed Web of Science ®Google Scholar
• Mukherjee H, Grimster NP. Beyond cysteine: recent developments in the area of targeted covalent inhibition. Curr Opin Chem Biol 2018;44:30–8.
   PubMed Web of Science ®Google Scholar
• Zhang T, Hatcher JM, Teng M, et al. Recent advances in selective and irreversible covalent ligand development and validation. Cell Chem Biol 2019;26:1486–500.
   PubMed Web of Science ®Google Scholar
• Pfizer’s novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study | Pfizer [Internet]. 2021 [cited 2021 Nov 6]. Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate.
   Google Scholar
• Cravatt BF, Wright AT, Kozarich JW. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu Rev Biochem 2008;77:383–414.
   PubMed Web of Science ®Google Scholar
• Shannon DA, Weerapana E. Covalent protein modification: the current landscape of residue-specific electrophiles. Curr Opin Chem Biol 2015;24:18–26.
   PubMed Web of Science ®Google Scholar
• Deng H, Lei Q, Wu Y, et al. Activity-based protein profiling: recent advances in medicinal chemistry. Eur J Med Chem 2020;191:112151.
   PubMed Web of Science ®Google Scholar
• Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 2011;91:119–49.
   PubMed Web of Science ®Google Scholar
• Gendaszewska-Darmach E, Garstka MA, Błażewska KM. Targeting small GTPases and their prenylation in diabetes mellitus. J Med Chem 2021;64:9677–710.
   PubMed Web of Science ®Google Scholar
• Pylypenko O, Rak A, Reents R, et al. Structure of Rab escort protein-1 in complex with Rab geranylgeranyltransferase. Mol Cell 2003;11:483–94.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Fiji HDG, Guo L, et al. Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds. J Biol Chem 2008;283:9571–9.
   PubMed Web of Science ®Google Scholar
• Tan KT, Guiu-Rozas E, Bon RS, et al. Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors. J Med Chem 2009;52:8025–37.
   PubMed Web of Science ®Google Scholar
• Stigter EA, Guo Z, Bon RS, et al. Development of selective, potent RabGGTase inhibitors. J Med Chem 2012;55:8330–40.
   PubMed Web of Science ®Google Scholar
• Deraeve C, Guo Z, Bon RS, et al. Psoromic acid is a selective and covalent rab-prenylation inhibitor targeting autoinhibited rabggtase. J Am Chem Soc 2012;134:7384–91.
   PubMed Web of Science ®Google Scholar
• Coxon FP, Helfrich MH, Larijani B, et al. Identification of a novel Phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem 2001;276:48213–22.
   PubMed Web of Science ®Google Scholar
• McKenna CE, Kashemirov BA, Błazewska KM, et al. Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic Acid. J Med Chem 2010;53:3454–64.
   PubMed Web of Science ®Google Scholar
• Kaźmierczak A, Kusy D, Niinivehmas SP, et al. Identification of the privileged position in the imidazo[1,2-a]pyridine ring of phosphonocarboxylates for development of Rab Geranylgeranyl Transferase (RGGT) inhibitors. J Med Chem 2017;60:8781–800.
   PubMed Web of Science ®Google Scholar
• Coxon F, Joachimiak Ł, Najumudeen AK, et al. Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT. Eur J Med Chem 2014;84:77–89.
   PubMed Web of Science ®Google Scholar
• Joachimiak Ł, Marchwicka A, Gendaszewska-Darmach E, et al. Synthesis and biological evaluation of imidazole-bearing α-phosphonocarboxylates as inhibitors of Rab Geranylgeranyl Transferase (RGGT). ChemMedChem 2018;13:842–51.
   PubMed Web of Science ®Google Scholar
• Lonsdale R, Burgess J, Colclough N, et al. Expanding the armory: predicting and tuning covalent warhead reactivity. J Chem Inf Model 2017;57:3124–37.
   PubMed Web of Science ®Google Scholar
• Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006;6:358–70.
   PubMed Web of Science ®Google Scholar
• Zhu K, Borrelli KW, Greenwood JR, et al. Docking covalent inhibitors: a parameter free approach to pose prediction and scoring. J Chem Inf Model 2014;54:1932–40.
   PubMed Web of Science ®Google Scholar
• Abo M, Li C, Weerapana E. Isotopically-labeled iodoacetamide-alkyne probes for quantitative cysteine-reactivity profiling. Mol Pharm 2018;15:743–9.
   PubMedGoogle Scholar
• Kalinin A, Thomä NH, Iakovenko A, et al. Expression of mammalian geranylgeranyltransferase type-II in escherichia coli and its application for in vitro prenylation of Rab proteins. Protein Expr Purif 2001;22:84–91.
   PubMed Web of Science ®Google Scholar
• Sidorovitch V, Niculae A, Kan N, et al. Expression of mammalian Rab Escort Protein-1 and -2 in yeast Saccharomyces cerevisiae. Protein Expr Purif 2002;26:50–8.
   PubMed Web of Science ®Google Scholar
• Alexandrov K, Simon I, Yurchenko V, et al. Characterization of the ternary complex between Rab7, REP-1 and Rab geranylgeranyl transferase. Eur J Biochem 1999;265:160–70.
   PubMedGoogle Scholar
• Rak A, Niculae A, Kalinin A, et al. In vitro assembly, purification, and crystallization of the rab geranylgeranyl transferase: substrate complex. Protein Expr Purif 2002;25:23–30.
   PubMed Web of Science ®Google Scholar
• Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2007;2:1896–906.
   PubMed Web of Science ®Google Scholar
• Kusy D, Wojciechowska A, Małolepsza J, et al. Functionalization of the imidazo[1,2-a]pyridine ring in α-phosphonoacrylates and α-phosphonopropionates via microwave-assisted Mizoroki-Heck reaction. Beilstein J Org Chem 2020;16:15–21.
   PubMed Web of Science ®Google Scholar
• Flanagan ME, Abramite JA, Anderson DP, et al. Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors. J Med Chem 2014;57:10072–9.
   PubMed Web of Science ®Google Scholar
• Petri L, Ábrányi-Balogh P, Varga PR, et al. Comparative reactivity analysis of small-molecule thiol surrogates. Bioorg Med Chem 2020;28:115357.
   PubMed Web of Science ®Google Scholar
• Lundblad RL, Chapter 2: alkylating agents. In: Chemical reagents for protein modification. 4th ed. CRC Press, Taylor & Francis Group; 2014:48–54.
   Google Scholar
• Ábrányi-Balogh P, Petri L, Imre T, et al. A road map for prioritizing warheads for cysteine targeting covalent inhibitors. Eur J Med Chem 2018;160:94–107.
   PubMed Web of Science ®Google Scholar